Medicare Enrolled
Dr. Huseng Vefali, M.D.
Cardiovascular Disease · Austin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vefali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vefali? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vefali
Dr. Huseng Vefali is a cardiovascular disease in Austin, TX, with 14 years in practice. Based on federal Medicare data, Dr. Vefali performed 1,267 Medicare services across 892 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vefali received a total of $29,824 from 56 pharmaceutical and/or device companies across 506 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vefali is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice▲ 1,267 Medicare services$ $29,824 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,267
Medicare services
Bottom 37% in TX for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
892
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~90 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 252 | $93 | $332 |
| Hospital follow-up visit, high complexity | 217 | $94 | $257 |
| Electrocardiogram (EKG), 12-lead | 134 | $11 | $85 |
| Echocardiogram, transthoracic | 97 | $149 | $760 |
| Initial hospital admission, high complexity | 79 | $136 | $498 |
| New patient office visit (45-59 min) | 65 | $127 | $427 |
| Critical care, first 30-74 min | 56 | $155 | $708 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 53 | $10 | $40 |
| Ultrasonic guidance for blood vessel access | 41 | $11 | $40 |
| Cardiac catheterization | 31 | $204 | $1,000 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 24 | $9 | $41 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 21 | $54 | $223 |
| Ultrasound of both sides of head and neck blood flow | 21 | $157 | $745 |
| Office visit, established patient, complex (40-54 min) | 20 | $142 | $462 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 19 | $60 | $1,220 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $11 | $37 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 19 | $18 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 18 | $17 | $55 |
| Office visit, established patient (20-29 min) | 17 | $55 | $234 |
| Transitional care management services for problem of at least moderate complexity | 16 | $157 | $529 |
| Ultrasound of heart, follow-up | 14 | $79 | $269 |
| Complete ultrasound study of arm and leg arteries | 12 | $92 | $353 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 11 | $18 | $69 |
| New patient office visit, complex (60-74 min) | 11 | $158 | $562 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.1% high complexity
9.8% medium
80.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$29,824
Total received (2018-2024)
Avg $4,261/year across 7 years
Top 15% in TX for cardiovascular disease
56
Companies
506
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,670 (89.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,154 (10.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,286
2023$4,032
2022$5,736
2021$5,022
2020$187
2019$4,528
2018$5,035
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$3,847
Medtronic Vascular, Inc.
$3,688
Medtronic, Inc.
$3,196
Bayer HealthCare Pharmaceuticals Inc.
$2,594
ShockWave Medical, Inc
$1,560
ABIOMED
$1,057
Amgen Inc.
$979
Biosense Webster, Inc.
$892
Philips North America LLC
$891
ACIST MEDICAL SYSTEMS, INC.
$804
Novartis Pharmaceuticals Corporation
$770
BIOTRONIK INC.
$757
Bayer Healthcare Pharmaceuticals Inc.
$736
Siemens Medical Solutions USA, Inc.
$713
BOSTON SCIENTIFIC CORPORATION
$692
Penumbra, Inc.
$672
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$614
Philips Electronics North America Corporation
$613
Boston Scientific Corporation
$577
Janssen Pharmaceuticals, Inc
$525
Impulse Dynamics (USA) Inc.
$480
Shockwave Medical, Inc
$339
Inari Medical, Inc.
$337
Cardiovascular Systems Inc.
$274
AstraZeneca Pharmaceuticals LP
$243
Kiniksa Pharmaceuticals, Ltd.
$193
iRhythm Technologies, Inc.
$166
Cleerly, Inc.
$154
Novo Nordisk Inc
$144
Merck Sharp & Dohme LLC
$142
CARDIVA MEDICAL, INC.
$133
Edwards Lifesciences Corporation
$100
Acist Medical Systems, Inc.
$88
PFIZER INC.
$71
GE HEALTHCARE
$68
Teleflex LLC
$60
Kiniksa Pharmaceuticals International, plc
$60
Esperion Therapeutics, Inc.
$58
Althera Pharmaceuticals LLC
$58
E.R. Squibb & Sons, L.L.C.
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Itamar Medical Inc
$43
AngioDynamics, Inc.
$39
Amarin Pharma Inc.
$38
ATRICURE, INC.
$32
Janssen Biotech, Inc.
$30
SCPHARMACEUTICALS INC.
$29
Baxter Healthcare
$25
GE HealthCare
$24
AGEPHA Pharma FZ LLC
$21
Opsens Inc.
$20
Terumo Medical Corporation
$17
G Medical Diagnostic Services, Inc.
$16
Regeneron Healthcare Solutions, Inc.
$15
Becton, Dickinson and Company
$15
Arbor Pharmaceuticals, Inc.
$11
Top 3 companies account for 36.0% of total payments
Associated products mentioned in payments ›
(4067) Tack Endovascular Systems BTK · (6536) Phoenix · (9520) IGT Devices Und · (BH4) IGT Devices Undivided · (BR5) Peripheral IVUS · (DD1) Duo Hybrid · ABRE · ALPHAVAC · AMPLATZER Occluders · AMPLATZER TALISMAN · ASSURITY · ATRICLIP LAA EXCLUSION SYSTEM · AVEIR · Accent Pacemaker · Allia · Arcalyst · Artis Q biplane · Assurity Pacemaker · Azure · BRILINTA · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CONFIRM RX · COREVALVE EVOLUT R · CVI Systems · Cardiac Monitoring Suite · Cleerly Ischemia · ClosureFast · Confirm Rx · CoreValve Evolut · Corlanor · DIAMONDBACK PERIPHERAL · Diamondback Peripheral · ELIQUIS · ELUVIA · ENTRESTO · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · GENERAL THERAPIES · General - Therapies · HD-IVUS · Hillrom - Cardiac Ambulatory Monitor · IGT D Coronary · IGT_D Coronary · IN.PACT ADMIRAL · Impella · Indigo System · JARDIANCE · JOT DX · Kerendia · LEQVIO · LODOCO · LUX-Dx Insertable Cardiac Monitor · LifeVest · MANTA Vascular Closure Device · METACROSS OTW · Mitra Clip system · NA · NEXLETOL · OPTICROSS · OPTIMIZER · OPTIS · Optimizer · OptoWire · Other · Ozempic · PERCLOSE PROGLIDE · PERCLOSE PROSTYLE · PRADAXA · PRALUENT · PRODIGY · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Quadra Allure MP RF CRT Pacemkr · RESOLUTE ONYX · RESONATE · Repatha · Reveal LINQ · Roszet · RotarexS 6 F x 135 cm · S · SC2000 · SHOCKWAVE INTRAVASCULAR LITHOTRIPSY (IVL) SYSTEM WITH THE SHOCKWAVE C2+ CORONARY · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SIMPONI ARIA · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TURNPIKE · TrapLiner Catheter · VENASEAL · VERQUVO · VYNDAQEL · Vascepa · Vascular Lithotripsy · WATCHMAN · WatchPATONE · XARELTO · XIENCE SIERRA · ZIO Patch · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $2,354 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
92
Per 100K population
7.0
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vefali is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 15%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vefali experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Vefali performed 252 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vefali receive payments from pharmaceutical companies?
Yes. Dr. Vefali received a total of $29,824 from 56 companies across 506 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vefali's costs compare to other cardiovascular diseases in Austin?
Dr. Vefali's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vefali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Austin
Browse cardiovascular diseases in Austin ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology